comparemela.com

Latest Breaking News On - Lisa coussens - Page 1 : comparemela.com

Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team

/PRNewswire/ Shasqi, Inc. ("Shasqi") a clinical stage biotech company, whose mission is to revolutionize cancer treatment with click chemistry, today.

United statesLisa coussensPatricia lorussoBristol myers squibbRobert wood johnsonYale collegeUniversity of strasbourgSenior advisor at boston consulting groupBlade therapeutics incDepartment of cellXdx incExperimental therapeutics at yale cancer centerOhio state universityDexus incPhasei clinical trials programAmerican association of cancer research

Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team

SAN FRANCISCO, Aug. 2, 2023 /PRNewswire/ Shasqi, Inc. ( Shasqi ) a clinical stage biotech company, whose mission is to revolutionize cancer tre.

United statesBristol myers squibbPatricia lorussoLisa coussensRobert wood johnsonNational cancer instituteAmerican society of clinical oncologyCarnegie mellon universityIndian institute of technology delhiYale collegeOhio state universityCornell universityExperimental therapeutics at yale cancer centerAmerican association of cancer researchXdx incUniversity of strasbourg

State of Cancer Research: Impact of COVID-19, Brexit, War, and Other Global Events

Cancer research has been hindered by the COVID-19 pandemic, Brexit, the war in Ukraine, and tensions between world superpowers.

United kingdomUnited statesCity ofLisa coussensRichard sullivanKing college londonOregon health sciences university in portlandOregon healthSciences universityCollege london

AACR 2023: In Review - BioTechniques

AACR 2023: In Review - BioTechniques
biotechniques.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biotechniques.com Daily Mail and Mail on Sunday newspapers.

United statesLisa coussensOregon healthScience universityAmerican association for cancer researchAmerican associationCancer researchPast president lisa coussens

Kineta Appoints Internationally-Renowned Clinical Immuno-oncology Experts to its Scientific Advisory Board

01.03.2023 - SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) - Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address cancer immune resistance, announced today the appointment of Myriam . Seite 1

Michael curranPatricia lorussoLisa coussensEvan ya wen yuThierry guillaudeuxMyriam chalabiKineta incScientific advisory boardChief scientific officer

vimarsana © 2020. All Rights Reserved.